# Bupivacaine vs Oxybuprocaine Topical Anesthesia in IVI

> **NCT05069350** · EARLY_PHASE1 · COMPLETED · sponsor: **Research Institute of Ophthalmology, Egypt** · enrollment: 100 (actual)

## Conditions studied

- Pain, Acute

## Interventions

- **DRUG:** bupivacaine 0.5% and oxubuprocaine

## Key facts

- **NCT ID:** NCT05069350
- **Lead sponsor:** Research Institute of Ophthalmology, Egypt
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-01
- **Primary completion:** 2022-08-01
- **Final completion:** 2022-08-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2022-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05069350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05069350, "Bupivacaine vs Oxybuprocaine Topical Anesthesia in IVI". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05069350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*